| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |